(News Bulletin 247) – Berenberg announced on Tuesday that it had initiated coverage of the Euroapi stock with a buy recommendation and a target price of 16.9 euros, representing an upside potential of 54% at current levels.
In a research note, the analyst highlights the breadth of the portfolio of this world leader in small molecule active pharmaceutical ingredients (APIs), whose 165 ingredients cover more than 80% of the manufacture of drugs currently approved by the US FDA.
After its split from Sanofi, the group should be able to focus on its high-margin products, he said, while leveraging unused capacity under a simplified corporate structure.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
